Author

H. Rahil

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biophysics· 2 Biochemistry· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:bacteria (other)· 1 Research Focus:cell signaling & trafficking· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:imaging· 1

Frequent Co-Authors

T. Hussain· 2 shared A. Chauvier· 1 shared A. Datey· 1 shared A. Graziadei· 1 shared A. Weixlbaumer· 1 shared C. Saint-Andre· 1 shared F. T. Khaja· 1 shared J. Rappsilber· 1 shared

Activity by Year

2021-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 19 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBiophysics

T. Hussain

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Yeast eukaryotic initiation factor 4B remodels the mRNA entry site on the small ribosomal subunit

A. Datey, F. T. Khaja, H. Rahil, T. Hussain

This study uses cryo-electron microscopy to determine the position of yeast eIF4B on the 40S ribosomal subunit and its role in mRNA recruitment.

Biochemistry · Jan 23, 2025Peer-reviewedBiophysics

Molecular basis of mRNA delivery to the bacterial ribosome

M. W. Webster, A. Chauvier, H. Rahil, A. Graziadei, K. Charles, M. Takacs, C. Saint-Andre, J. Rappsilber, N. G. Walter, A. Weixlbaumer

This study investigates how bS1 facilitates mRNA delivery to the ribosome and enhances translation initiation by RNAP in bacteria.

bioRxiv · Mar 19, 2024Biochemistry

Drug targeting Nsp1-ribosomal complex shows antiviral activity against SARS-CoV-2

T. Hussain, M. Afsar, R. Narayan, M. N. Akhtar, H. Rahil, S. Eswarappa, S. Tripathi

This study identifies montelukast sodium hydrate as a potential antiviral drug against SARS-CoV-2 by targeting the Nsp1-ribosomal complex and reducing viral replication in cell cultures.

bioRxiv · Nov 2, 2021Biophysics